Bone Turnover Markers in Patients with Ossification of the Posterior Longitudinal Ligament in the Thoracic Spine.


Journal

Spine
ISSN: 1528-1159
Titre abrégé: Spine (Phila Pa 1976)
Pays: United States
ID NLM: 7610646

Informations de publication

Date de publication:
19 Jun 2023
Historique:
received: 29 03 2023
accepted: 07 06 2023
medline: 20 6 2023
pubmed: 20 6 2023
entrez: 20 6 2023
Statut: aheadofprint

Résumé

A prospective, single-center, observational study. To explore the association between serum levels of bone turnover markers and ossification of the posterior longitudinal ligament (OPLL) in the thoracic spine. The relationship between bone turnover markers, such as N-terminal propeptide of type Ⅰ procollagen (PⅠNP) or tartrate-resistant acid phosphate 5b (TRACP-5b), and OPLL has previously been examined. However, the correlation between these markers and thoracic OPLL, which is more severe than cervical-only OPLL, remains unclear. This prospective study included 212 patients from a single institution with compressive spinal myelopathy and divided them into those without OPLL (Non-OPLL group, 73 patients) and those with OPLL (OPLL group, 139 patients). The OPLL group was further subdivided into cervical OPLL (C-OPLL, 92 patients) and thoracic OPLL (T-OPLL, 47 patients) groups. Patients' characteristics and biomarkers related to bone metabolism, such as calcium, inorganic phosphate (Pi), 25-hydroxyvitamin D, 1α,25-dihydroxyvitamin D, PⅠNP, and TRACP-5b, were compared between the Non-OPLL and OPLL groups, as well as the C-OPLL and T-OPLL groups. Bone metabolism biomarkers were also compared after adjusting for age, sex, body mass index, and the presence of renal impairment using propensity score-matched analysis. The OPLL group had significantly lower serum levels of Pi and higher levels of PⅠNP versus the Non-OPLL group as determined by propensity score-matched analysis. The comparison results between the C-OPLL and T-OPLL groups using a propensity score-matched analysis showed that T-OPLL patients had significantly higher concentrations of bone turnover markers, such as PⅠNP and TRACP-5b, compared to C-OPLL patients. Increased systemic bone turnover may be associated with the presence of OPLL in the thoracic spine and bone turnover markers such as PⅠNP and TRACP-5b can help screen for thoracic OPLL.

Sections du résumé

STUDY DESIGN METHODS
A prospective, single-center, observational study.
OBJECTIVE OBJECTIVE
To explore the association between serum levels of bone turnover markers and ossification of the posterior longitudinal ligament (OPLL) in the thoracic spine.
SUMMARY OF BACKGROUND DATA BACKGROUND
The relationship between bone turnover markers, such as N-terminal propeptide of type Ⅰ procollagen (PⅠNP) or tartrate-resistant acid phosphate 5b (TRACP-5b), and OPLL has previously been examined. However, the correlation between these markers and thoracic OPLL, which is more severe than cervical-only OPLL, remains unclear.
METHODS METHODS
This prospective study included 212 patients from a single institution with compressive spinal myelopathy and divided them into those without OPLL (Non-OPLL group, 73 patients) and those with OPLL (OPLL group, 139 patients). The OPLL group was further subdivided into cervical OPLL (C-OPLL, 92 patients) and thoracic OPLL (T-OPLL, 47 patients) groups. Patients' characteristics and biomarkers related to bone metabolism, such as calcium, inorganic phosphate (Pi), 25-hydroxyvitamin D, 1α,25-dihydroxyvitamin D, PⅠNP, and TRACP-5b, were compared between the Non-OPLL and OPLL groups, as well as the C-OPLL and T-OPLL groups. Bone metabolism biomarkers were also compared after adjusting for age, sex, body mass index, and the presence of renal impairment using propensity score-matched analysis.
RESULTS RESULTS
The OPLL group had significantly lower serum levels of Pi and higher levels of PⅠNP versus the Non-OPLL group as determined by propensity score-matched analysis. The comparison results between the C-OPLL and T-OPLL groups using a propensity score-matched analysis showed that T-OPLL patients had significantly higher concentrations of bone turnover markers, such as PⅠNP and TRACP-5b, compared to C-OPLL patients.
CONCLUSION CONCLUSIONS
Increased systemic bone turnover may be associated with the presence of OPLL in the thoracic spine and bone turnover markers such as PⅠNP and TRACP-5b can help screen for thoracic OPLL.

Identifiants

pubmed: 37339262
doi: 10.1097/BRS.0000000000004753
pii: 00007632-990000000-00387
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest and source of support: This manuscript does not contain information regarding medical device(s)/drug(s). No funds were received in support of this work. No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.

Auteurs

Katsuyuki Sasaki (K)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Toru Doi (T)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.
Department of Orthopaedic Surgery, Tokyo Women's Medical University, Tokyo, Japan 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.

Tomohisa Inoue (T)

Department of Orthopaedic Surgery, Tokyo Women's Medical University, Tokyo, Japan 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.

Keiichiro Tozawa (K)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Hiroyuki Nakarai (H)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Yuichi Yoshida (Y)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Yusuke Ito (Y)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Nozomu Ohtomo (N)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Ryuji Sakamoto (R)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Koji Nakajima (K)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Kosei Nagata (K)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Naoki Okamoto (N)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Hideki Nakamoto (H)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

So Kato (S)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Yuki Taniguchi (Y)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Yoshitaka Matsubayashi (Y)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Ken Okazaki (K)

Department of Orthopaedic Surgery, Tokyo Women's Medical University, Tokyo, Japan 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.

Sakae Tanaka (S)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Yasushi Oshima (Y)

Department of Orthopaedic Surgery, The University of Tokyo, Tokyo, Japan 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Classifications MeSH